Titelbild

Partnering

Topas is open to various types of collaboration. The Company plans to partner its proprietary programs at the clinical or pre-clinical stage on an option or a classical licensing basis with biotech or pharmaceutical companies. Topas is also interested in pre-clinical co-development agreements with biotech or academia that have complementary know-how and capabilities. Furthermore, Topas remains open to collaborating with pharmaceutical and biotech companies on selected indications proposed by the respective partner.

Upcoming Events

18th Annual Biotech in Europe Forum (Sachs Forum)

Basel/CH
Oct. 4-5, 2018

ECTRIMS 2018

Berlin/FRG
Oct. 10-12, 2018

16th International Diabetes Society Congress

London/UK
Oct. 25-29, 2018

BIO-Europe

Copenhagen/DK
Nov. 5-7, 2018

Antigen-Specific Immune Tolerance Conference

London/UK
Dec. 10-12, 2018

JP Morgan Healthcare Conference

San Francisco/US
Jan. 7-10, 2019